Skip to Main Content

Author Details

Leonard Da Silva
Pathology Queensland The Royal Brisbane and Women's Hospital Brisbane Qld Australia.
2007
34
24
PMIDPaper TitleJournal TitlePublished Year
33363813Phenotypic drift in metastatic progression of breast cancer: A case report with histologically heterogeneous lesions that are clonally related.Clin Case Rep2020
33363813Phenotypic drift in metastatic progression of breast cancer: A case report with histologically heterogeneous lesions that are clonally related.Clin Case Rep2020
29344954Mixed ductal-lobular carcinomas: evidence for progression from ductal to lobular morphology.J Pathol2018
29344954Mixed ductal-lobular carcinomas: evidence for progression from ductal to lobular morphology.J Pathol2018
27087319Point Mutations in Exon 1B of APC Reveal Gastric Adenocarcinoma and Proximal Polyposis of the Stomach as a Familial Adenomatous Polyposis Variant.Am J Hum Genet2016
27148852The calcium pump plasma membrane Ca(2+)-ATPase 2 (PMCA2) regulates breast cancer cell proliferation and sensitivity to doxorubicin.Sci Rep2016
27087319Point Mutations in Exon 1B of APC Reveal Gastric Adenocarcinoma and Proximal Polyposis of the Stomach as a Familial Adenomatous Polyposis Variant.Am J Hum Genet2016
26510554An epithelial to mesenchymal transition programme does not usually drive the phenotype of invasive lobular carcinomas.J Pathol2016
26510554An epithelial to mesenchymal transition programme does not usually drive the phenotype of invasive lobular carcinomas.J Pathol2016
27148852The calcium pump plasma membrane Ca(2+)-ATPase 2 (PMCA2) regulates breast cancer cell proliferation and sensitivity to doxorubicin.Sci Rep2016
25668816Heregulin-HER3-HER2 signaling promotes matrix metalloproteinase-dependent blood-brain-barrier transendothelial migration of human breast cancer cell lines.Oncotarget2015
25668816Heregulin-HER3-HER2 signaling promotes matrix metalloproteinase-dependent blood-brain-barrier transendothelial migration of human breast cancer cell lines.Oncotarget2015
26172396Integrated genomic and transcriptomic analysis of human brain metastases identifies alterations of potential clinical significance.J Pathol2015
26172396Integrated genomic and transcriptomic analysis of human brain metastases identifies alterations of potential clinical significance.J Pathol2015
24811120Rad51 supports triple negative breast cancer metastasis.Oncotarget2014
24811120Rad51 supports triple negative breast cancer metastasis.Oncotarget2014
22815804Expression and function of the protein tyrosine phosphatase receptor J (PTPRJ) in normal mammary epithelial cells and breast tumors.PLoS One2012
22807578Calcium channel TRPV6 as a potential therapeutic target in estrogen receptor-negative breast cancer.Mol Cancer Ther2012
22718308Gene expression profiling of tumour epithelial and stromal compartments during breast cancer progression.Breast Cancer Res Treat2012
22815804Expression and function of the protein tyrosine phosphatase receptor J (PTPRJ) in normal mammary epithelial cells and breast tumors.PLoS One2012
22718308Gene expression profiling of tumour epithelial and stromal compartments during breast cancer progression.Breast Cancer Res Treat2012
22807578Calcium channel TRPV6 as a potential therapeutic target in estrogen receptor-negative breast cancer.Mol Cancer Ther2012
21394826Splicing and multifactorial analysis of intronic BRCA1 and BRCA2 sequence variants identifies clinically significant splicing aberrations up to 12 nucleotides from the intron/exon boundary.Hum Mutat2011
22567347Molecular aspects of breast cancer metastasis to the brain.Genet Res Int2011
21394826Splicing and multifactorial analysis of intronic BRCA1 and BRCA2 sequence variants identifies clinically significant splicing aberrations up to 12 nucleotides from the intron/exon boundary.Hum Mutat2011
21499728Tumor heterogeneity in a follicular carcinoma of thyroid: a study by comparative genomic hybridization.Endocr Pathol2011
21787400Rare variants in the ATM gene and risk of breast cancer.Breast Cancer Res2011
22567347Molecular aspects of breast cancer metastasis to the brain.Genet Res Int2011
21787400Rare variants in the ATM gene and risk of breast cancer.Breast Cancer Res2011
21499728Tumor heterogeneity in a follicular carcinoma of thyroid: a study by comparative genomic hybridization.Endocr Pathol2011
20020529Bayes analysis provides evidence of pathogenicity for the BRCA1 c.135-1G>T (IVS3-1) and BRCA2 c.7977-1G>C (IVS17-1) variants displaying in vitro splicing results of equivocal clinical significance.Hum Mutat2010
20577821The contribution of breast cancer pathology to statistical models to predict mutation risk in BRCA carriers.Fam Cancer2010
20436502Pathology of hereditary breast cancer.Mod Pathol2010
20604919HER3 and downstream pathways are involved in colonization of brain metastases from breast cancer.Breast Cancer Res2010
20513136Detection of splicing aberrations caused by BRCA1 and BRCA2 sequence variants encoding missense substitutions: implications for prediction of pathogenicity.Hum Mutat2010
20206335DNA methylome of familial breast cancer identifies distinct profiles defined by mutation status.Am J Hum Genet2010
20593485Gene expression profiling of formalin-fixed, paraffin-embedded familial breast tumours using the whole genome-DASL assay.J Pathol2010
19960244Subtypes of familial breast tumours revealed by expression and copy number profiling.Breast Cancer Res Treat2010
20020529Bayes analysis provides evidence of pathogenicity for the BRCA1 c.135-1G>T (IVS3-1) and BRCA2 c.7977-1G>C (IVS17-1) variants displaying in vitro splicing results of equivocal clinical significance.Hum Mutat2010
20642837Dissecting the transcriptional networks underlying breast cancer: NR4A1 reduces the migration of normal and breast cancer cell lines.Breast Cancer Res2010
20513136Detection of splicing aberrations caused by BRCA1 and BRCA2 sequence variants encoding missense substitutions: implications for prediction of pathogenicity.Hum Mutat2010
20577821The contribution of breast cancer pathology to statistical models to predict mutation risk in BRCA carriers.Fam Cancer2010
20604919HER3 and downstream pathways are involved in colonization of brain metastases from breast cancer.Breast Cancer Res2010
20593485Gene expression profiling of formalin-fixed, paraffin-embedded familial breast tumours using the whole genome-DASL assay.J Pathol2010
20642837Dissecting the transcriptional networks underlying breast cancer: NR4A1 reduces the migration of normal and breast cancer cell lines.Breast Cancer Res2010
20206335DNA methylome of familial breast cancer identifies distinct profiles defined by mutation status.Am J Hum Genet2010
20436502Pathology of hereditary breast cancer.Mod Pathol2010
19960244Subtypes of familial breast tumours revealed by expression and copy number profiling.Breast Cancer Res Treat2010
19031084Molecular and morphological analysis of adenoid cystic carcinoma of the breast with synchronous tubular adenosis.Virchows Arch2009
19047897Molecular evidence for progression of microglandular adenosis (MGA) to invasive carcinoma.Am J Surg Pathol2009
  • 1 - 50 of 68

Recommended Authors

Memorial Sloan Kettering Cancer Center
Career Start Year 2014
Number of shared co-authors 3
Instituto Do Cancer Do Estado de Sao Paulo
Career Start Year 2009
Number of shared co-authors 9
University of Bern
Career Start Year 2009
Number of shared co-authors 6
Stanford University School of Medicine
Career Start Year 2008
Number of shared co-authors 2
University of Basel
Career Start Year 2008
Number of shared co-authors 6
Memorial Sloan Kettering Cancer Center
Career Start Year 2007
Number of shared co-authors 7
Westmead Institute for Medical Research, Westmead Hospital, The University of Sydney
Career Start Year 2006
Number of shared co-authors 4
University of Turin, Candiolo Cancer Institute, FPO-IRCCS
Career Start Year 2005
Number of shared co-authors 5
Beth Israel Deaconess Medical Center, Harvard Medical School
Career Start Year 2004
Number of shared co-authors 11
Memorial Sloan Kettering Cancer Center
Career Start Year 2002
Number of shared co-authors 11
Olivia Newton-John Cancer Research Institute
Career Start Year 2002
Number of shared co-authors 6
IEO European Institute of Oncology IRCCS
Career Start Year 2002
Number of shared co-authors 2
UCD Conway Institute, University College Dublin
Career Start Year 2001
Number of shared co-authors 0
Universite Libre de Bruxelles
Career Start Year 2000
Number of shared co-authors 10
The University of Texas MD Anderson Cancer Center
Career Start Year 1998
Number of shared co-authors 1
Lund University and Skane University Hospital
Career Start Year 1997
Number of shared co-authors 2
University Health Network
Career Start Year 1994
Number of shared co-authors 1
Cancer Research UK Cambridge Institute, University of Cambridge
Career Start Year 1992
Number of shared co-authors 26
University of Edinburgh
Career Start Year 1992
Number of shared co-authors 6
Fred Hutchinson Cancer Research Center
Career Start Year 1991
Number of shared co-authors 1
Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School
Career Start Year 1991
Number of shared co-authors 2
Institutet of Bioinformatics, University Hospital of Munster, University of Munster
Career Start Year 1990
Number of shared co-authors 2
Vanderbilt University Medical Center
Career Start Year 1990
Number of shared co-authors 5
University Medical Center Utrecht
Career Start Year 1989
Number of shared co-authors 5
Erasmus Medical Center (MC) Cancer Institute
Career Start Year 1989
Number of shared co-authors 19
Thomas Jefferson University Hospital
Career Start Year 1988
Number of shared co-authors 5
Queen Elizabeth University Hospital
Career Start Year 1986
Number of shared co-authors 0
University of California San Francisco
Career Start Year 1984
Number of shared co-authors 22
Pathologisches Institut, Universitatsklinikum Heidelberg
Career Start Year 1981
Number of shared co-authors 14
Foundation Medicine
Career Start Year 1974
Number of shared co-authors 1

Collaborators

University of Queensland
Co-authored papers 34
UQ Centre for Clinical Research, The University of Queensland
Co-authored papers 21
QIMR Berghofer Medical Research Institute
Co-authored papers 13
QIMR Berghofer Medical Research Institute
Co-authored papers 9
QIMR Berghofer Medical Research Institute
Co-authored papers 7
University of Utah
Co-authored papers 6
QIMR Berghofer Medical Research Institute
Co-authored papers 6
QIMR Berghofer Medical Research Institute
Co-authored papers 3
QIMR Berghofer Medical Research Institute
Co-authored papers 3
QIMR Berghofer Medical Research Institute
Co-authored papers 3
Mayo Clinic
Co-authored papers 3
QIMR Berghofer Medical Research Institute
Co-authored papers 3
QIMR Berghofer Medical Research Institute
Co-authored papers 3
Ludwig Institute for Cancer Research Ltd.
Co-authored papers 2
Co-authored papers 2
University of Hull
Co-authored papers 2
UCL Institute of Prion Diseases
Co-authored papers 2
The Queensland Institute of Medical Research
Co-authored papers 2
QIMR Berghofer Medical Research Institute
Co-authored papers 2
The University of Melbourne
Co-authored papers 2
Westmead Institute for Medical Research, The University of Sydney
Co-authored papers 2
Memorial Sloan-Kettering Cancer Center
Co-authored papers 1
Australia UNSW RNA Institute
Co-authored papers 1
Co-authored papers 1
SA Pathology at the Women's and Children's Hospital
Co-authored papers 1
QIMR Berghofer Medical Research Institute
Co-authored papers 1
Institute of Functional Genomics, University of Regensburg
Co-authored papers 1
National Institute of Diabetes and Digestive and Kidney Diseases
Co-authored papers 1
Ferdowsi University of Mashhad
Co-authored papers 1
Mayo Clinic
Co-authored papers 1